In vivo tumor suppressing and anti-angiogenic activities of a recombinant anti-CD3 ε nanobody in breast cancer mice model

Immunotherapy, Ahead of Print.

Source: Immunotherapy - December 9, 2019 Category: Allergy & Immunology Authors: Azadeh Sharif Khatibi Nasim Hayati Roodbari Keivan Majidzade-A Parichehreh Yaghmaei Leila Farahmand Source Type: research